This is quite similar to the results of Harada et al. [51] who did ROC curve analysis and found that the optimal cut-off value of adiponectin to detect sarcopenia in CVD patients (males and females) including cardiovascular surgery was 5.62 μg/ml. Here, ADIPOQ is linked to sarcopenia.